Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial
Authors:
- Fabio ParazziniFPFabio Parazzini
- Elisabetta Di CintioECElisabetta Di Cintio
- Liliane ChatenoudLCLiliane Chatenoud
- Simona MoroniSMSimona Moroni
- Italo ArdovinoIAItalo Ardovino
- Elisario StruzzieroESElisario Struzziero
- Leopoldo FalsettiLFLeopoldo Falsetti
- Albino BianchiABAlbino Bianchi
- Gianluca BraccoGBGianluca Bracco
- Alessandra PellegriniAPAlessandra Pellegrini
- Carlo BertulessiCBCarlo Bertulessi
- Carlo RomaniniCRCarlo Romanini
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 88 (1) , 11-14
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Does contraception modify the risk of endometriosis?Human Reproduction, 1993
- Depot leuprolide versus danazol in treatment of women with symptomatic endometriosisAmerican Journal of Obstetrics and Gynecology, 1992
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-upFertility and Sterility, 1992
- Clinical Manifestations and Classification of EndometriosisClinical Obstetrics and Gynecology, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- An epidemiologic study of young women with dysmenorrheaAmerican Journal of Obstetrics and Gynecology, 1982